back

The injectable pharmaceutical market is experiencing unprecedented growth, fuelled by innovative pharma products, expanding applications and rising consumer demand. However, this success brings increased concerns over patient adherence.

This expansion has transformed the industry, with an injectable drug product market value of $762.48Bn by 2028 predicted by research firm McKinsey. This growth makes it essential to address the challenges of low patient adherence with self-administered treatments, and the rising global challenge of counterfeiting.

At MM Packaging, we're committed to addressing these challenges head-on by providing cutting-edge packaging solutions, tailored to the unique needs of the injectable pharma sector.

The challenges posed by injectable pharma products, both to the pharma business and the end patients, can be supported with packaging solutions. The key lies in using packaging technology to make products safer, more reliable, and interactive.

Adherence is one of the most prominent challenges; it’s vital that self-medicating patients stick to strict schedules and are using the product in its intended way. Without the oversight of healthcare professionals, patients must take responsibility for following dosage schedules and administration techniques accurately. Poor adherence can also contribute to increased healthcare costs and strains on healthcare systems. Therefore, providing clear and comprehensive instructions, along with tools like smart packaging solutions that support adherence, is crucial for empowering patients to self-manage their health effectively.

Further, injectable products tend to have a higher price point, which makes the market more attractive to counterfeit product manufacturers, who may attempt to infiltrate the market with illicit and unregulated products and put patient safety at significant risk.

Perfectly complementing our carton, leaflet and label product range, we offer innovative smart packaging solutions such as Near-Field Communication (NFC) and Radio Frequency Identification (RFID) technology.

NFC technology protects patients from counterfeit injectable products by enabling real-time tracing throughout the supply chain. RFID technology facilitates automated tracking, reducing the risk of counterfeit activities and unauthorised tampering. These smart technologies provide transparency, ensuring the authenticity of injectable pharmaceutical products from production to consumption.

In addition to smart packaging technology, our range includes anti-counterfeit solutions designed to protect patients and end users from illicit or fake drug products. We have partnered with Crane Authentication to offer micro-optic anti-counterfeiting solutions. PROFOUND™ Micro-Optics technology, used to protect valuable bank notes around the globe. This enables easy at-a-glance authentication of genuine products that counterfeiters cannot easily replicate.

As the injectable market expands, ensuring patient safety and product authenticity is paramount. MM Packaging is dedicated to providing innovative packaging solutions that address the unique challenges of the injectable pharma market.

Contact us today to learn more about our comprehensive range of solutions and unlock a safer, more secure future in the injectable pharma market.